===
EQS-News: Medios AG / Key word(s): Investment
Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
2024-06-20 / 10:02 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press Release
Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
Berlin, June 20, 2024 - Medios, a leading provider of Specialty Pharma in Europe, was today informed that Manfred
Schneider has reallocated all of his shares in Medios AG. Schneider's shares, which corresponds to a total of 14.9% of
Medios' share capital, were sold to the investment company Luxempart S.A. as part of a private placement. Schneider had
held some of the shares sold via his companies Tangaroa Management GmbH and Tangaroa GmbH & Co. KG.
Matthias Gaertner, Chairman of the Executive Board of Medios: "On behalf of the Executive Board, I would like to thank
Manfred Schneider for his many years of commitment to Medios. As founder and former CEO, he has had a strong influence
on our Company. With his clear vision and the right strategic decisions, he laid the foundation for the dynamic growth
and ongoing success of the Medios Group.
With the establishment of a European Specialty Pharma platform, we are currently at an exciting turning point. We are
therefore very pleased to have Luxempart as a new strategic anchor shareholder and are convinced that Luxempart is
exactly the right partner for the internationalization of our Company, which has just begun, and the associated next
phase of growth. As a solid, internationally experienced strategic investor with a well-founded network and know-how,
Luxempart can support us very well in this process."

About Luxempart
Luxempart is a Luxembourg-based listed investment company with a net worth of EUR 2.3bn backed by Luxembourgish
entrepreneurial families. With permanent capital and a professional investment team, Luxempart provides flexible
long-term financing solutions to entrepreneurs, families and management and actively supports its portfolio companies
in their growth and international expansion. Luxempart's Direct Investment strategy consists in investing equity
tickets ranging from EUR25m up to EUR100m in the DACH region, France, Benelux countries and Northern Italy.

About Medios AG
Medios is a leading provider of Specialty Pharma in Europe. With locations in Germany, the Netherlands, Belgium and
Spain, the company supports key partners in the supply chain with innovative solutions and intelligent services. Medios
has focused on pioneering individualized medicine to make the most innovative therapies available to everyone together
with pharmacies, specialist practices and pharmaceutical companies.
Medios AG is Germany's first listed specialty pharmaceutical company and is listed on the Regulated Market of the
Frankfurt Stock Exchange (Prime Standard).

www.medios.ag

Contact
Claudia Nickolaus
Head of Investor & Public Relations, ESG Communications
Medios AG
Heidestraße 9 | 10557 Berlin
T +49 30 232 566 800
ir@medios.group
www.medios.ag

Disclaimer
This communication contains forward-looking statements that are subject to certain risks and uncertainties. Future
results could differ materially from those currently anticipated as a result of various risk factors and uncertainties,
including, but not limited to, changes in business, economic and competitive conditions, foreign exchange rate
fluctuations, uncertainties in litigation or investigative proceedings and the availability of financing.
2024-06-20 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      Medios AG 

Heidestraße 9
10557 Berlin
Germany

Phone:        +49 30 232 566 - 800 
Fax:          +49 30 232 566 - 801 
E-mail:       ir@medios.ag 
Internet:     www.medios.ag 
ISIN:         DE000A1MMCC8 
WKN:          A1MMCC 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 

Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1929793

End of News EQS News Service
===
1929793 2024-06-20 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1929793&application_name=news

END) Dow Jones Newswires

June 20, 2024 04:02 ET (08:02 GMT)